Glioblastoma (GBM) is the most common kind of malignant brain tumor in adults. In recent years, the tumor microenvironment ...

Innovative drug development "the flavor of 2025" says Ali Pashazadeh, who discusses how the new administration will likely ...

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

GEN webinar, experts from AbbVie and Benchling will share insights into the current tech landscape, AI readiness, and the ...

StitchR makes it possible to deliver larger payloads with current vectors, expanding the list of diseases targetable by gene therapies.

Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.